Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adoptive immunotherapy for adenovirus-associated complications after hematopoietic stem cell transplantation
ISRCTN14732774Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cidofovir and Placebo-COD Research Private Ltd in adenoviral infection (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Treatment-related mortality. Started Jul 2006; status: completed.
02
Drugs
cidofovirPlacebo-COD Research Private Ltd
03
Conditions
adenoviral infection
Beyond the preview
Go deeper on ISRCTN14732774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14732774.